AURINIA PHARMACEUTICALS

Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis, focal segmental glomerulosclerosis, and Dry Eye Syndrome.

#People #Financial #Website #More

AURINIA PHARMACEUTICALS

Social Links:

Facebook

Twitter

Industry:

Biopharma Biotechnology Health Care Medical Therapeutics

Founded:

2011-01-01

Address:

Victoria, British Columbia, Canada

Country:

Canada

Website Url:

http://www.auriniapharma.com

Total Employee:

251+

Status:

Active

Contact:

+1 (250) 744-2487

Email Addresses:

[email protected]

Total Funding:

658.46 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache

Current Advisors List

richard-glickman_image

Richard Glickman Chairman of the Board of Directors @ Aurinia Pharmaceuticals
Board_member

brinda-balakrishnan_image

Brinda Balakrishnan Board Member @ Aurinia Pharmaceuticals
Board_member
2021-06-01

Current Employees Featured

neil-solomons_image

Neil Solomons
Neil Solomons Chief Medical Officer and co-founder @ Aurinia Pharmaceuticals
Chief Medical Officer and co-founder
2013-09-01

richard-glickman_image

Richard Glickman
Richard Glickman Co Founder @ Aurinia Pharmaceuticals
Co Founder

michael-martin_image

Michael Martin
Michael Martin Chief Operating Officer @ Aurinia Pharmaceuticals
Chief Operating Officer

richard-glickman_image

Richard Glickman
Richard Glickman CEO @ Aurinia Pharmaceuticals
CEO
2017-02-01

max-donley_image

Max Donley
Max Donley Executive Vice President, Internal Operations and Strategy @ Aurinia Pharmaceuticals
Executive Vice President, Internal Operations and Strategy

max-colao_image

Max Colao
Max Colao CCO @ Aurinia Pharmaceuticals
CCO

robert-huizinga_image

Robert Huizinga
Robert Huizinga Executive Vice President, Research @ Aurinia Pharmaceuticals
Executive Vice President, Research
2020-10-01

Founder

michael-martin_image

Michael Martin

neil-solomons_image

Neil Solomons

richard-glickman_image

Richard Glickman

robert-huizinga_image

Robert Huizinga

Stock Details

Company's stock symbol is NASDAQ:AUPH

Acquisitions List

Date	Company	Article	Price
2013-02-05	Isotechnika Pharma	Isotechnika Pharma acquired by Aurinia Pharmaceuticals	N/A

Investors List

apple-tree-partners_image

Official Site Inspections

http://www.auriniapharma.com Semrush global rank: 1.9 M Semrush visits lastest month: 11.51 K

Host Informations
Whois Informations

Loading ...